Anzeige
Mehr »
Mittwoch, 25.06.2025 - Börsentäglich über 12.000 News
TAO +1.800?%, SBAR +85?%, CYK +280?% - jetzt startet KORA auf Unternehmensebene durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A415CY | ISIN: US76090R4083 | Ticker-Symbol: 24O0
NASDAQ
25.06.25 | 21:23
2,500 US-Dollar
-3,85 % -0,100
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
RESHAPE LIFESCIENCES INC Chart 1 Jahr
5-Tage-Chart
RESHAPE LIFESCIENCES INC 5-Tage-Chart

Aktuelle News zur RESHAPE LIFESCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
RESHAPE LIFESCIENCES Aktie jetzt für 0€ handeln
14:46ReShape Lifesciences erhält australisches Patent für Diabetes-Gerät2
14:42ReShape Lifesciences receives Australian patent for diabetes device1
14:36ReShape Lifesciences Inc: ReShape Lifesciences Granted Key International Patent in Australia for Its Proprietary Diabetes Neuromodulation Technology1
18.06.ReShape Lifesciences Inc. - 8-K, Current Report1
12.06.ReShape Lifesciences Inc: ReShape Lifesciences Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets827IRVINE, Calif., June 12, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the signing of...
► Artikel lesen
09.06.ReShape Lifesciences prices $2.6M public offering3
09.06.ReShape Lifesciences Inc. - 8-K, Current Report1
09.06.ReShape Lifesciences sets share price at $2.50 in public offering1
09.06.ReShape Lifesciences legt Aktienpreis bei 2,50 US-Dollar für öffentliches Angebot fest5
09.06.ReShape Lifesciences Inc: ReShape Lifesciences Announces Pricing of $2.6 Million Public Offering1
03.06.Why ReShape Lifesciences Stock Is Soaring Today: Key Drivers Behind Weight-Loss Company's Surge2
03.06.ReShape Lifesciences achieves EU and UK medical device certification6
03.06.ReShape Lifesciences Inc: ReShape Lifesciences Announces EU MDR Certification for Entire European and United Kingdom Product Portfolio178IRVINE, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that its Quality...
► Artikel lesen
28.05.ReShape Lifesciences Inc. - 8-K, Current Report3
21.05.ReShape Lifesciences GAAP EPS of -$18.98, revenue of $1.1M2
21.05.ReShape Lifesciences Inc: ReShape Lifesciences Reports First Quarter Ended March 31, 2025 Financial Results and Provides Corporate Update4
20.05.ReShape Lifesciences Inc. - 10-Q, Quarterly Report1
09.05.ReShape Lifesciences Inc. - S-4/A, Registration of securities, business combinations3
07.05.ReShape Lifesciences announces 1-for-25 reverse stock split2
07.05.ReShape Lifesciences kündigt Aktienzusammenlegung im Verhältnis 1:25 an5
Weiter >>
56 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1